SCHEMBL7997384

SCHEMBL7997384

CCCCCCCCCCCC(C)NC(=O)/C=C/c1ccc(-c2[nH]c(-c3ccc(/C=C/C(=O)OCC)cc3)nc2-c2ccc(OCC(=O)O)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ SELP P16109 6/20 0.46
▸ SELE P16581 2/20 0.46
▸ TAS1R3 Q7RTX0 2/20 0.42
▸ TAS1R1 Q7RTX1 2/20 0.42
▸ PTPN1 P18031 1/20 0.40
▸ ADORA2B P29275 3/20 0.40
▸ ADORA3 P0DMS8 2/20 0.40
▸ ABCB1 P08183 1/20 0.39
▸ P2RY12 Q9H244 1/20 0.39
▸ MPO P05164 1/20 0.37
▸ ADORA2A P29274 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ FABP4 P15090 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7997394 1.00 MEN1 (0.49) MEN1KMT2ASELPSELETAS1R3
SCHEMBL8194916 0.88 SELP (0.58) MEN1KMT2ASELPSELEPTPN1
SCHEMBL8194911 0.88 SELP (0.58) MEN1KMT2ASELPSELEPTPN1
SCHEMBL7997425 0.87 MEN1 (0.46) MEN1KMT2ASELPSELETAS1R3
SCHEMBL7997432 0.87 MEN1 (0.46) MEN1KMT2ASELPSELETAS1R3
SCHEMBL7995394 0.84 SELP (0.67) MEN1KMT2ASELPSELETAS1R3
SCHEMBL7995405 0.84 SELP (0.67) MEN1KMT2ASELPSELETAS1R3
SCHEMBL8000298 0.84 SELP (0.53) MEN1KMT2ASELPSELEPTPN1
SCHEMBL7995368 0.84 SELP (0.53) MEN1KMT2ASELPSELEPTPN1
SCHEMBL7993112 0.82 MEN1 (0.54) MEN1KMT2ASELPSELEPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000033836-A9 5-MEMBERED HETEROCYCLES FOR THE TREATMENT OF HUMAN DISEASES INVOLVING MODULATORS OF SELECTINS ONTOGEN CORP (US) 2001-10-04 — — WO disclosed
WO-2000033836-A1 5-MEMBERED HETEROCYCLES FOR THE TREATMENT OF HUMAN DISEASES INVOLVING MODULATORS OF SELECTINS ONTOGEN CORPORATION (US) 2000-06-15 — — WO disclosed
Send feedback